Downregulation of BCL11A by siRNA induces apoptosis in B lymphoma cell lines

Gao,Yangjun; Wu,Hong; He,Dongmei; Hu,Xiaomao; Li,Yangqiu

doi:10.3892/br.2012.9

Downregulation of BCL11A by siRNA induces apoptosis in B lymphoma cell lines

Authors:
- Yangjun Gao
- Hong Wu
- Dongmei He
- Xiaomao Hu
- Yangqiu Li
View Affiliations

Affiliations: Institute of Hematology, Medical College, Jinan University, Guangzhou, Guangdong 510632, P.R. China
Published online on: September 5, 2012 https://doi.org/10.3892/br.2012.9
Pages: 47-52

Metrics: Total Views: 0 (Spandidos Publications: | PMC Statistics: )

Metrics: Total PDF Downloads: 0 (Spandidos Publications: | PMC Statistics: )

Cited By (CrossRef): 0 citations Loading Articles...

Abstract

The B‑cell chronic lymphocytic leukemia (CLL)/lymphoma 11A gene (BCL11A) encodes a krüppel‑like zinc finger protein, which is important in thymopoiesis and has been associated with hematopoietic malignancies. In this study, we investigated whether the downregulation of BCL11A mRNA by small interference RNA (siRNA) was capable of inducing apoptosis, and tested the effect of BCL11A siRNA combined with BCL2 siRNA in B lymphoma cell lines (SUDHL6, EB1). BCL11A siRNA was transfected into SUDHL6, EB1 cells with HiPerfect transfection reagents. After transient transfection with BCL11A siRNA, the expression levels of BCL11A mRNA and protein were assayed by quantitative reverse transcription polymerase chain reaction (qRT‑PCR) and western blot analysis. The cell proliferation was determined by a cell counting kit‑8 (CCK8) assay. Apoptosis was determined by morphological observation and flow cytometric analysis. The results showed that the expression levels of BCL11A mRNA and protein from SUDHL6, EB1 cells transfected with BCL11A siRNA decreased, compared with either the scrambled negative control siRNA group or untransfected cells group (P<0.05). Viability of cells transfected with BCL11A siRNA was less compared to cells transfected with control siRNA and untransfected SUDHL6, EB1 cells, respectively (P<0.05). BCL11A siRNA induced apoptosis in both SUDHL6 and EB1 cells. BCL11A siRNA combined with BCL2 siRNA significantly inhibited cell growth. Apoptotic rates of SUDHL6, EB1 cells treated with BCL11A siRNA combined with BCL2 siRNA significantly increased (P<0.05), compared with either the scrambled control (Sc) siRNA and BCL2 siRNA combination or BCL2 or BCL11A siRNA‑treated cells alone. Findings of this study suggest the downregulation of BCL11A mRNA by siRNA was able to induce apoptosis. Moreover, BCL11A siRNA combined with BCL2 siRNA increased apoptosis in SUDHL6, EB1 cells. Thus, suppression of BCL11A expression may be a useful approach in the treatment of B lymphoma.

View Figures

View References

1.	Nakamura T, Yamazaki Y, Saiki Y, Moriyama M, Largaespada DA, Jenkins NA and Copeland NG: Evi9 encodes a novel zinc finger protein that physically interacts with BCL6, a known human B-cell proto-oncogene product. Mol Cell Biol. 20:3178–3186. 2000. View Article : Google Scholar : PubMed/NCBI
2.	Liu P, Keller JR, Ortiz M, et al: Bcl11a is essential for normal lymphoid development. Nat Immunol. 4:525–532. 2003. View Article : Google Scholar : PubMed/NCBI
3.	Satterwhite E, Sonoki T, Willis TG, et al: The BCL11 gene family: involvement of BCL11 A in lymphoid malignancies. Blood. 98:3413–3420. 2001. View Article : Google Scholar : PubMed/NCBI
4.	Hystad ME, Myklebust JH, Bø TH, et al: Characterization of early stages of human B cell development by gene expression profiling. J Immunol. 179:3662–3671. 2007. View Article : Google Scholar : PubMed/NCBI
5.	Martín-Subero JI, Gesk S, Harder L, et al: Recurrent involvement of the REL and BCL11A loci in classical Hodgkin lymphoma. Blood. 99:1474–1477. 2002.PubMed/NCBI
6.	Weniger MA, Pulford K, Gesk S, et al: Gains of the proto-oncogene BCL11A and nuclear accumulation of BCL11A(XL) protein are frequent in primary mediastinal B-cell lymphoma. Leukemia. 20:1880–1882. 2006. View Article : Google Scholar : PubMed/NCBI
7.	Liu H, Ippolito GC, Wall JK, et al: Functional studies of BCL11A: characterization of the conserved BCL11A-XL splice variant and its interaction with BCL6 in nuclear paraspeckles of germinal center B cells. Mol Cancer. 5:182006. View Article : Google Scholar : PubMed/NCBI
8.	Yin B, Delwel R, Valk PJ, Wallace MR, Loh ML, Shannon KM and Largaespada DA: A retroviral mutagenesis screen reveals strong cooperation between Bcl11a overexpression and loss of the Nf1 tumor suppressor gene. Blood. 113:1075–1085. 2009. View Article : Google Scholar : PubMed/NCBI
9.	Gao Y, He D, Chen S, Yan X, Hu X and Li Y: Quantitative detection of BCL11A gene expression B cell malignancies by real-time RT-PCR. J Jinan Univ Med Ed. 32:147–150. 2011.(In Chinese).
10.	Gao Y, He D, Chen S, Yan X, Hu X and Li Y: Expression of the B-cell lymphoma/leukemia 11A gene in malignant hematological cell lines through quantitative reverse transcription polymerase chain reaction. Clin Oncol Cancer Res. 8:242–246. 2011. View Article : Google Scholar
11.	Kirkin V, Joos S and Zornig M: The role of Bcl-2 family members in tumorigenesis. Biochim Biophys Acta. 1644:229–249. 2004. View Article : Google Scholar : PubMed/NCBI
12.	He D and Fang B: Small hairpin RNA targeting at Bcl-2 increases cytarabine-induced apoptosis in Raji cells. Acta Biochim Biophys Sin. 41:131–136. 2009. View Article : Google Scholar : PubMed/NCBI
13.	Cioca DP, Aoki YJ and Kiyosawa K: RNA interference is a functional pathway with therapeutic potential in human myeloid leukemia cell lines. Cancer Gene Ther. 10:125–133. 2003. View Article : Google Scholar : PubMed/NCBI
14.	Schmittgen TD and Livak KJ: Analyzing real-time PCR data by the comparative C(T) method. Nat Protoc. 3:1101–1108. 2008. View Article : Google Scholar : PubMed/NCBI
15.	Livak KJ and Schmittgen TD: Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) method. Methods. 25:402–408. 2001. View Article : Google Scholar : PubMed/NCBI
16.	Xu J, Sankaran VG, Ni M, Menne TF, Puram RV, Kim W and Orkin SH: Transcriptional silencing of {gamma}-globin by BCL11A involves long-range interactions and cooperation with SOX6. Genes Dev. 24:783–798. 2010.
17.	Sankaran VG, Menne TF, Xu J, et al: Human fetal hemoglobin expression is regulated by the developmental stage-specific repressor BCL11A. Science. 322:1839–1842. 2008. View Article : Google Scholar : PubMed/NCBI
18.	Huang X, Chen S, Shen Q, et al: Down regulation of BCL11B expression inhibits proliferation and induces apoptosis in malignant T cells by BCL11B-935-siRNA. Hematology. 16:236–242. 2011. View Article : Google Scholar : PubMed/NCBI
19.	Grabarczyk P, Przybylski GK, Depke M, et al: Inhibition of BCL11B expression leads to apoptosis of malignant but not normal mature T cells. Oncogene. 26:3797–3810. 2007. View Article : Google Scholar : PubMed/NCBI
20.	Karanam NK, Grabarczyk P, Hammer E, et al: Proteome analysis reveals new mechanisms of Bcl11b-loss driven apoptosis. J Proteome Res. 9:3799–3811. 2010. View Article : Google Scholar : PubMed/NCBI
21.	Li L, Leid M and Rothenberg EV: An early T cell lineage commitment checkpoint dependent on the transcription factor Bcl11b. Science. 329:89–93. 2010. View Article : Google Scholar : PubMed/NCBI
22.	Huang X, Chen S, Shen Q, et al: Analysis of the expression pattern of the BCL11B gene and its relatives in patients with T-cell acute lymphoblastic leukemia. J Hematol Oncol. 3:442010. View Article : Google Scholar : PubMed/NCBI
23.	Karlsson A, Nordigården A, Jönsson JI and Söderkvist P: Bcl11b mutations identified in murine lymphomas increase the proliferation rate of hematopoietic progenitor cells. BMC Cancer. 7:1952007. View Article : Google Scholar : PubMed/NCBI
24.	Avram D, Fields A, Top KP, Nevrivy DJ, Ishmael JE and Leid M: Isolation of a novel family of C(2)H(2) zinc finger proteins implicated in transcriptional repression mediated by chicken ovalbumin upstream promoter transcription factor (COUP-TF) orphan nuclear receptors. J Biol Chem. 275:10315–10322. 2000. View Article : Google Scholar
25.	Biroccio A, Leonetti C and Zupi G: The future of antisense therapy: combination with anticancer treatments. Oncogene. 22:6579–6588. 2003. View Article : Google Scholar : PubMed/NCBI
26.	Xing XK, Li SJ, He JL and Chen Z: Inhibition of hepatitis C virus replication by single and dual small interfering RNA using an HCV-infected cell model. Biotechnol Lett. 34:295–301. 2012. View Article : Google Scholar : PubMed/NCBI